Malignant Glioma Developed on a Patient Under Deep Brain Stimulation: Pitfalls in Management.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 22 04 2019
revised: 24 05 2019
accepted: 25 05 2019
pubmed: 4 6 2019
medline: 17 1 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

Glioblastoma (GBM) is the most common aggressive malignant primary brain tumor, rarely concurrent in patients who require deep brain stimulation (DBS) implants. Despite the high incidence of these circumstances alone, the coexistence of both in a patient has been seldom reported. In this paper, we report a case of a patient suffering from a movement disorder treated with DBS who developed a GBM. A patient with bilateral DBS of the globus pallidus internus for refractory secondary dystonia developed a GBM close to the electrode leads, 2.5 years after implantation. The clinical findings, medical management and pitfalls, and possible relationship between the DBS device and the tumor development are discussed. We withdrew the system to perform brain magnetic resonance imaging safely. This revealed an extended lesion that was biopsied. The removal led to a clinical worsening that resulted in fatality, without the possibility of receiving adjuvant treatment. The available literature shows similar management, which depends mainly on the stimulation system used. We advise the use of magnetic resonance imaging-safe devices; otherwise, we recommend keeping the system and proceeding with computed tomography imaging for diagnostic and management if necessary. The true relationship between chronic DBS stimulation and GBM is to be clarified.

Sections du résumé

BACKGROUND BACKGROUND
Glioblastoma (GBM) is the most common aggressive malignant primary brain tumor, rarely concurrent in patients who require deep brain stimulation (DBS) implants. Despite the high incidence of these circumstances alone, the coexistence of both in a patient has been seldom reported. In this paper, we report a case of a patient suffering from a movement disorder treated with DBS who developed a GBM.
CASE DESCRIPTION METHODS
A patient with bilateral DBS of the globus pallidus internus for refractory secondary dystonia developed a GBM close to the electrode leads, 2.5 years after implantation. The clinical findings, medical management and pitfalls, and possible relationship between the DBS device and the tumor development are discussed. We withdrew the system to perform brain magnetic resonance imaging safely. This revealed an extended lesion that was biopsied. The removal led to a clinical worsening that resulted in fatality, without the possibility of receiving adjuvant treatment. The available literature shows similar management, which depends mainly on the stimulation system used.
CONCLUSIONS CONCLUSIONS
We advise the use of magnetic resonance imaging-safe devices; otherwise, we recommend keeping the system and proceeding with computed tomography imaging for diagnostic and management if necessary. The true relationship between chronic DBS stimulation and GBM is to be clarified.

Identifiants

pubmed: 31158542
pii: S1878-8750(19)31511-6
doi: 10.1016/j.wneu.2019.05.234
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

85-89

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Pedro Roldán (P)

Institut Clínic de Neurociències (ICN), Department of Neurological Surgery, Hospital Clínic de Barcelona, Universidad de Barcelona, Barcelona, Spain; Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

Rafael Najarro (R)

Institut Clínic de Neurociències (ICN), Department of Neurological Surgery, Hospital Clínic de Barcelona, Universidad de Barcelona, Barcelona, Spain.

Alberto Di Somma (A)

Institut Clínic de Neurociències (ICN), Department of Neurological Surgery, Hospital Clínic de Barcelona, Universidad de Barcelona, Barcelona, Spain. Electronic address: albertodisomma87@gmail.com.

Diego Culebras (D)

Institut Clínic de Neurociències (ICN), Department of Neurological Surgery, Hospital Clínic de Barcelona, Universidad de Barcelona, Barcelona, Spain.

Jhon Alexander Hoyos (JA)

Institut Clínic de Neurociències (ICN), Department of Neurological Surgery, Hospital Clínic de Barcelona, Universidad de Barcelona, Barcelona, Spain.

Yaroslau Compta (Y)

Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

Ana Cámara (A)

Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

Esteban Muñoz (E)

Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

María José Martí (MJ)

Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

Francesc Valldeoriola (F)

Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

Jordi Rumià (J)

Institut Clínic de Neurociències (ICN), Department of Neurological Surgery, Hospital Clínic de Barcelona, Universidad de Barcelona, Barcelona, Spain; Parkinsons Disease & Movement Disorders Unit, Neurology Department, Hospital Clínic de Barcelona / IDIBAPS / University of Barcelona, Institut de Neurociències, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH